title: Preventing thalassemia in Lebanon: successes and challenges in a developing country.
abstract: Thalassemia continues to be a major health burden. The chronicity of the disease and the high cost of life-long treatment make prevention strategies crucial in the management of this disease. In this article, we revisit different successful prevention strategies, and underline the Lebanese model. The Chronic Care Center (CCC), Beirut, is the only specialized center in Lebanon for the treatment and prevention of thalassemia. The current number of patients registered up to August 2013 was 724, representing cases from all over Lebanon. In 1994, the center launched a national prevention program following the World Health Organization (WHO) recommendations. The major activities of the program include awareness campaigns, screening for thalassemia carriers in the general population and high risk groups, registry of new cases and follow-up on the mandatory premarital law (established at the same time). Screening programs showed a carrier rate of around 2.3% in the general population, and 4.0-41.0% in high risk groups. The major pitfall in the law is that only persons with a mean corpuscular volume (MCV) of >70.0 fL are asked to perform further hemoglobin (Hb) testing. A significant decrease in the number of new cases of thalassemia patients in Lebanon reflects the efforts deployed in the prevention of the disease. However, some limitations are faced in reaching a complete eradication of the disease, mainly due to the fact that abortion is illegal and due to pitfalls and incorrect implementation of the premarital law.
authors.affiliation: Chronic Care Center , Beirut , Lebanon.
authors.forename: Michele
authors.initials: M
authors.lastname: Abi Saad
authors.forename: Anthony G
authors.initials: AG
authors.lastname: Haddad
authors.forename: Elie S
authors.initials: ES
authors.lastname: Alam
authors.forename: Sanaa
authors.initials: S
authors.lastname: Aoun
authors.forename: Pascale
authors.initials: P
authors.lastname: Maatouk
authors.forename: Najat
authors.initials: N
authors.lastname: Ajami
authors.forename: Therese
authors.initials: T
authors.lastname: Khairallah
authors.forename: Suzanne
authors.initials: S
authors.lastname: Koussa
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Musallam
authors.forename: Ali T
authors.initials: AT
authors.lastname: Taher
mesh_terms: D054626:Consumer Health Information; D003906:Developing Countries; D006580:Genetic Carrier Screening; D005817:Genetic Counseling; D005820:Genetic Testing / Q000331:legislation & jurisprudence; D006293:Health Promotion / Q000331:legislation & jurisprudence; D006801:Humans; D015994:Incidence; D007861:Lebanon / Q000453:epidemiology; D009154:Mutation; D011291:Premarital Examinations; D012042:Registries; D013789:Thalassemia / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control* / Q000628:therapy
keywords: Developing country; Lebanon; prevention; thalassemia